Comparative performance of risk prediction models for hepatitis B-related hepatocellular carcinoma in the United States.
Comparative performance of risk prediction models for hepatitis B-related hepatocellular carcinoma in the United States. J Hepatol. 2022 02; 76(2):294-301.